NeuroPace NPCE
NASDAQ NPCE
$13.79 -0.85 (-5.80%)
At close: Aug 20, 2026 · 1:09 PM UTC

NeuroPace (NPCE) EBIT Margin (2020 - 2026)

NeuroPace (NPCE) posted quarterly EBIT Margin of 25.23% for Q1 2026, down 238.0% year-over-year from 18.28% in Q1 2025, and down 279.65% quarter-over-quarter from 6.65% in Q4 2025.

NeuroPace (NPCE) EBIT Margin (2020 - 2026) Analysis & Trends

NeuroPace's EBIT Margin history runs 7 years deep, the most recent figure standing at 25.23% for Q1 2026.

  • In Q1 2026, EBIT Margin fell 238.0% year-over-year to 25.23%; the TTM figure through Mar 2026 stood at 16.84% (up 602.0% YoY), while the FY2025 annual figure was 16.34%, up 1078.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 25.23%, down from 6.65% in the prior quarter.
  • The five-year high for EBIT Margin was 6.65% in Q4 2025, with the low at 107.59% in Q2 2022.
  • The 5-year median for EBIT Margin is 32.35% (2024), against an average of 43.27%.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin tumbled 7113 bps in 2022, then jumped 6002 bps in 2023.
  • NeuroPace's EBIT Margin stood at 77.09% in 2022, then surged by 64 bps to 28.04% in 2023, then surged by 39 bps to 17.02% in 2024, then jumped by 61 bps to 6.65% in 2025, then tumbled by 280 bps to 25.23% in 2026.
  • Business Quant data shows NPCE's EBIT Margin at 25.23% in Q1 2026, 6.65% in Q4 2025, and 9.51% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 13.44%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 25.18%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 19.10%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 21.65%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 29.48%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 24.33%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 13.96%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 10.30%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 19.15%
10 NeuroPace 468.25 Mn 416.55 Mn 18.91 Mn -22.53%

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.53%
Mar 31, 2026 -25.23%
Dec 31, 2025 -6.65%
Sep 30, 2025 -9.51%
Jun 30, 2025 -29.01%
Mar 31, 2025 -22.85%
Dec 31, 2024 -17.02%
Sep 30, 2024 -20.15%
Jun 30, 2024 -32.35%
Mar 31, 2024 -41.63%
Dec 31, 2023 -28.04%
Sep 30, 2023 -36.22%
Jun 30, 2023 -47.57%
Mar 31, 2023 -57.48%
Dec 31, 2022 -77.09%
Sep 30, 2022 -91.41%
Jun 30, 2022 -107.59%
Mar 31, 2022 -85.83%
Dec 31, 2021 -81.98%
Sep 30, 2021 -60.38%